Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients

BACKGROUND: We investigated whether early dynamic changes of circulating free (cfDNA) levels as well as the neutrophil to lymphocyte ratio (NLR) could predict nivolumab effectiveness in pretreated patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 45 patients receiving ni...

Descripción completa

Detalles Bibliográficos
Autores principales: Passiglia, Francesco, Galvano, Antonio, Castiglia, Marta, Incorvaia, Lorena, Calò, Valentina, Listì, Angela, Mazzarisi, Salvatore, Perez, Alessandro, Gallina, Giuseppe, Rizzo, Sergio, Soto Parra, Hector, Bazan, Viviana, Russo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469277/
https://www.ncbi.nlm.nih.gov/pubmed/31019571
http://dx.doi.org/10.1177/1758835919839928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469277/
https://www.ncbi.nlm.nih.gov/pubmed/31019571
http://dx.doi.org/10.1177/1758835919839928

Ejemplares similares